Kisspeptin (KISS1) and its receptor (KISS1r) are essential for normal reproductive function in many species, but the role of kiss1/kiss1r signalling in the dog has not yet been elucidated. The aims of this study were to identify the canine kiss1 and kiss1r genes and to determine gonadotrophin and oestradiol stimulatory activity of KP-10, the shortest biologically active form of KISS1. Canine kiss1 and kiss1r genes were localized by comparing the reference dog genome with relevant human cDNA sequences, using BLASTn software. The amino acid sequence of canine KP-10 (YNWNV FGLRY) differs at two positions from human KP-10 (YNWNS FGLRF). A single bolus of canine KP-10 was administered intravenously to anoestrous Beagle bitches in dosages of 0, 0.1, 0.2, 0.3, 0.5, 1, 5, 10, and 30 μg/kg. Blood samples were collected before and after canine KP-10 administration for the measurement of plasma luteinizing hormone (LH, all doses), follicle-stimulating hormone (FSH) and oestradiol (1-30 μg/kg). From 0.2 μg/kg onwards, canine KP-10 resulted in a rapid and robust rise in plasma LH concentration (max. at 10 min). KP-10 also resulted in a rapid and robust rise in plasma FSH concentration (max. at 10-20 min). Plasma oestradiol concentration increased significantly after dosages of 1, 5, and 10 μg/kg and reached a maximum at 60-90 min. In conclusion, canine KP-10 is a potent kisspeptin which elicits robust gonadotrophin and oestradiol responses in anoestrous bitches, suggesting that canine kiss1/kiss1r are cogent targets for modulating reproduction in dogs.

Keywords:
Luteinizing hormone, Follicle-stimulating hormone, kiss1, kiss1r, GPR54, Canine, Bitch, Reproduction
1.
Colledge WH: GPR54 and kisspeptins. Results Probl Cell Differ 2008;46:117-143.
2.
Dedes I: Kisspeptins and the control of gonadotrophin secretion. Syst Biol Reprod Med 2012;58:121-128.
3.
Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Le Poul E, Brézillon S, Tyldesley R, Suarez-Huerta N, Vandeput F, Blanpain C, Schiffmann SN, Vassart G, Parmentier M: The metastasis suppressor gene KISS-1 encodes kisspeptins, the natural ligands of the orphan g protein-coupled receptor GPR54. J Biol Chem 2001;276:34631-34636.
4.
Oakley AE, Clifton DK, Steiner RA: Kisspeptin signaling in the brain. Endocr Rev 2009;30:713-743.
5.
Chan YM, Broder-Fingert S, Paraschos S, Lapatto R, Au M, Hughes V, Bianco SDC, Min L, Plummer L, Cerrato F, De Guillebon A, Wu AH, Wahab F, Dwyer A, Kirsch S, Quinton, R, Cheetham T, Ozata M, Ten S, Chanoine JP, Pitteloud N, Martin KA, Schiffmann R, Van der Kamp HJ, Nader S, Hall JE, Kaiser UB, Seminara SB: GnRH-deficient phenotypes in humans and mice with heterozygous variants in KISS1/Kiss1. J Clin Endocrinol Metab 2011;96:1771-1781.
6.
d'Anglemont de Tassigny X, Fagg LA, Dixon JP, Day K, Leitch HG, Hendrick AG, Zahn D, Franceschini I, Caraty A, Carlton MB, Aparicio SA, Colledge WH: Hypogonadotropic hypogonadism in mice lacking a functional Kiss1 gene. Proc Natl Acad Sci USA 2007;104:10714-10719.
7.
de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E: Hypogonadotropic hypogonadism due to loss of function of the KISS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 2003;100:10972-10976.
8.
Lapatto R, Pallais JC, Zhang D, Chan YM: Kiss1_/_ mice exhibit more variable hypogonadism than GPR54_/_ mice. Endocrinology 2007;148:4927-4936.
9.
Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS Jr, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Carlton MB, Crowley WF Jr, Aparicio SA, Colledge WH: The GPR54 gene as a regulator of puberty. N Engl J Med 2003;349:1614-1627.
10.
Topaloglu AK, Tello JA, Kotan LD, Ozbek MN, Yilmaz MB, Erdogan S, Gurbuz F, Temiz F, Millar RP, Yuksel B: Inactivating KISS1 mutation and hypogonadotropic hypogonadism. N Engl J Med 2012;366:629-635.
11.
Silveira LG, Noel SD, Silveira-Neto AP, Abreu AP, Brito VN, Santos MG, Bianco SD, Kuohung W, Xu S, Gryngarten M, Escobar ME, Arnhold IJ, Mendonca BB, Kaiser UB, Latronico AC: Mutations of the KISS1 gene in disorders of puberty. J Clin Endocrinol Metab 2010;95:2276-2280.
12.
Teles MG, Bianco SD, Brito VN, Trarbach EB, Kuohung W, Xu S, Seminara SB, Mendonca BB, Kaiser UB, Latronico AC: A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med 2008;358:709-715.
13.
Curtis AE, Cooke JH, Baxter JE, Parkinson JRC, Bataveljic A, Ghatei MA, Bloom SR, Murphy KG: A kisspeptin-10 analog with greater in vivo bioactivity than kisspeptin-10. Am J Physiol Endocrinol Metab 2009;298:296-303.
14.
Dhillo WS, Chaudhri OB, Thompson EL, Murphy KG, Patterson M, Ramachandran R, Nijher GK, Amber V, Kokkinos A, Donaldson M, Ghatei MA, Bloom SR: Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. J Clin Endocrinol Metab 2007;82:3958-3966.
15.
Gottsch ML, Cunningham MJ, Smith JT, Popa SM, Acohido BV, Crowley WF, Seminara S, Clifton DK, Steiner RA: A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology 2004;145:4073-4077.
16.
Hashizume T, Saito H, Sawada T, Yaegashi T, Ezzat AA, Sawai K, Yamashita T: Characteristics of stimulation of gonadotropin secretion by kisspeptin-10 in female goats. Anim Reprod Sci 2010;118:37-41.
17.
Mikkelsen JD, Bentsen AH, Ansel L, Simonneaux V, Juul A: Comparison of the effects of peripherally administered kisspeptins. Regul Pept 2009;152:95-100.
18.
Thompson EL, Patterson M, Murphy KG, Smith KL, Dhillo WS, Todd JF, Ghatei MA, Bloom SR: Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol 2004;16:850-858.
19.
Pineda R, Garcia-Galiano D, Roseweir A, Romero AM, Sanchez-Garrido MA, Ruiz-Pino F, Morgan K, Pinilla L, Millar RP, Tena-Sempere M: Critical roles of kisspeptins in female puberty and preovulatory gonadotropin surges as revealed by a novel antagonist. Endocrinology 2010;151:722-730.
20.
Smith JT, Li Q, Yap KS, Shahab M, Roseweir AK, Millar RP, Clarke IJ: Kisspeptin is essential for the full preovulatory LH surge and stimulates GnRH release from the isolated ovine median eminence. Endocrinology 2011;152:1001-1012.
21.
Herbison AE: Estrogen positive feedback to gonadotropin-releasing hormone (GnRH) neurons in the rodent: the case for the rostral periventricular area of the third ventricle (RP3V). Brain Res Rev 2008;57:277-287.
22.
Roa J, Aguilar E, Dieguez C, Pinilla L, Tena-Sempere M: New frontiers in kisspeptin/GPR54 physiology as fundamental gatekeepers of reproductive function. Front Neuroendocrinol 2008;29:48-69.
23.
Roseweir AK, Millar RP: Update: The role of kisspeptin in the control of gonadotrophin secretion. Hum Reprod 2009;15:203-212.
24.
Schaefers-Okkens AC, Kooistra HS: Ovaries; in Rijnberk A, Kooistra HS (eds): Clinical Endocrinology of Dogs and Cats, ed 2. Hanover, Schlutersche, 2010, pp 203-234.
25.
McGinnis S, Madden TL: BLAST: at the core of a powerful and diverse set of sequence analysis tools. Nucleic Acids Res 2004;32:20-25.
26.
Reese MG, Eeckman FH, Kulp D, Haussler D: Improved splice site detection in genie. J Comp Biol 1997;4:311-323.
27.
Okkens AC, Bevers MM, Dieleman SJ, Willemse AH: Shortening of the interoestrous interval and the lifespan of the corpus luteum of the cyclic dog by bromocriptine treatment. Vet Quart 1985;7:173-176.
28.
Concannon PW, Hansel W, McKentee K: Changes in LH, progesterone and sexual behaviour associated with preovulatory luteinization in the bitch. Biol Reprod 1977;17:604-613.
29.
Wildt DE, Panko WB, Chakraborty PK, Seager SWJ: Relationship of serum estrone, estradiol-17b and progesterone to LH, sexual behavior and time of ovulation in the bitch. Biol Reprod 1979;20:648-658.
30.
Okkens AC, Teunissen JM, van Osch W, van den Brom WE, Dieleman SJ, Kooistra HS: Influence of litter size and breed on the duration of gestation in dogs. J Reprod Fertil Suppl 2001;57:193-197.
31.
Kooistra HS, Okkens AC, Bevers MM, Poppsnijders C, van Haaften B, Dieleman SJ, Schoemaker J: Concurrent pulsatile secretion of luteinizing hormone and follicle-stimulating hormone during different phases of the estrous cycle and anestrus in beagle bitches. Biol Reprod 1999;60:65-71.
32.
Nett TM, Akbar AM, Phemister RD, Holst PA, Reichert LE Jr, Niswender GD: Levels of luteinizing hormone, estradiol and progesterone in serum during the estrous cycle and pregnancy in the beagle bitch. Proc Soc Exp Biol Med 1975;148:134-139.
33.
Beijerink NJ, Buijtels JJ, Okkens AC, Kooistra HS, Dieleman SJ: Basal and GnRH induced secretion of FSH and LH in anestrous versus ovariectomized bitches. Theriogenology 2007;67:1039-1045.
34.
Dieleman SJ, Bevers MM: Effects of monoclonal antibody against PMSG administered shortly after the preovulatory LH surge on time and number of ovulations in PMSG/PG-treated cows. J Reprod Fertil 1987;81:533-542.
35.
van Haaften B, Bevers MM, van den Brom WE, Okkens AC, van Sluijs FJ, Willemse AH, Dieleman SJ: Increasing sensitivity of the pituitary to GnRH from early to late anoestrus in the beagle bitch. J Reprod Fertil 1994;101:221-222.
36.
Millar RP, Roseweir AK, Tello JA, Anderson RA, George JT, Morgan K, Pawson AJ: Kisspeptin antagonists: unraveling the role of kisspeptin in reproductive physiology. Brain Res 2010;1364:81-89.
37.
Hiden U, Bilban M, Knöfler M, Desoye G: Kisspeptins and the placenta: regulation of trophoblast invasion. Rev Endocr Metab Disord 2007;8:31-39.
38.
George JT, Veldhuis JD, Roseweir AK, Newton CL, Faccenda E, Millar RP, Anderson RA: Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. J Clin Endocrinol Metab 2011;96:1228-1236.
39.
George JT, Anderson RA, Millar RP: Kisspeptin-10 stimulation of gonadotrophin secretion in women is modulated by sex steroid feedback. Hum Reprod 2012;27:3552-3559.
40.
Ezzat AA, Saito H, Sawada T, Yaegashi T, Yamashita T, Hirata T, Hashizume T: Characteristics of the stimulatory effect of kisspeptin-10 on the secretion of luteinizing hormone, follicle-stimulating hormone and growth hormone in prepubertal male and female cattle. J Reprod Dev 2009;55:650-654.
41.
Pheng V, Uenoyama Y, Homma T, Inamoto Y, Takase K, Yoshizawa-Kumagaye K, Isaka S, Watanabe TX, Ohkura S, Tomikawa J, Maeda K, Tsukamura H: Potencies of centrally or peripherally injected full-length kisspeptin or its C-terminal decapeptide on LH release in intact male rats. J Reprod Dev 2009;55:378-382.
42.
Smith JT, Li Q, Yap KS, Shahab M, Roseweir AK, Millar RP, Clarke IJ: Kisspeptin is essential for the full preovulatory LH surge and stimulates GnRH release from the isolated ovine median eminence. Endocrinology 2011;152:1001-1012.
43.
de Gier J, Buijtels JJ, Albers-Wolthers CH, Oei CH, Kooistra HS, Okkens AC: Effects of gonadotropin-releasing hormone administration on the pituitary-gonadal axis in male and female dogs before and after gonadectomy. Theriogenology 2012;77:967-978.
44.
Buijtels JJ, Beijerink NJ, Kooistra HS, Dieleman SJ, Okkens AC: Effects of gonadotrophin releasing hormone administration on the pituitary-ovarian axis in anoestrous vs ovariectomized bitches. Reprod Domest Anim 2006;41:555-561.
45.
Roseweir AK, Kauffman AS, Smith JT, Guerriero KA, Morgan K, Pielecka-Fortuna J, Pineda R, Gottsch ML, Tena-Sempere M, Moenter SM, Terasawa E, Clarke IJ, Steiner RA, Millar RP: Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation. J Neurosci 2009;29:3920-3929.
46.
Saito H, Sawada T, Yaegashi T, Goto Y, Jin J, Sawai K, Hashizume T: Kisspeptin-10 stimulates the release of luteinizing hormone and testosterone in pre- and post-pubertal male goats. Anim Sci J 2012;83:487-492.
47.
Schwartz NB: The 1994 Stevenson award lecture. Follicle-stimulating hormone and luteinizing hormone: a tale of two gonadotropins. Can J Physiol Pharmacol 1995;73:675-684.
48.
de Gier J, Kooistra HS, Djajadiningrat-Laanen SC, Dieleman SJ, Okkens AC: Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17b, progesterone, prolactin, and a-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch. Theriogenology 2006;65:1346-1359.
49.
Mann GE, Campbell BK, McNeilly AS, Baird DT: The role of inhibin and oestradiol in the control of FSH secretion in the sheep. J Endocrinol 1992;133:381-391.
50.
Wintermantel TM, Campbell RE, Porteous R, Bock D, Gröne HJ, Todman MG, Korach KS, Greiner E, Pérez CA, Schütz G, Herbison AE: Definition for estrogen receptor pathway critical for estrogen positive feedback to gonadotropin-releasing hormone neurons and fertility. Neuron 2006;52:271-280.
51.
Smith JT, Cunningham MJ, Rissman EF, Clifton DK, Steiner RA: Regulation of Kiss1 gene expression in the brain of the female mouse. Endocrinology 2005;146:3686-3692.
52.
Young KA: Differential ovarian expression of KiSS-1 and GPR-54 during the estrous cycle and photoperiod induced recrudescence in Siberian hamsters (Phodopus sungorus). Mol Reprod 2009;76:444-452.
53.
Dhillo WS, Chaudhri OB, Thompson EL, Murphy KG, Patterson M, Ramachandran R, Nijher GK, Amber V, Kokkinos A, Donaldson M, Ghatei MA, Bloom SR: Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. J Clin Endocrinol Metab 2007;92:3958-3966.
54.
Whitlock BK, Daniel JA, Wilborn RR, Rodning SP, Maxwell HS, Steele BP, Sartin JL: Interaction of estrogen and progesterone on kisspeptin-10-stimulated luteinizing hormone and growth hormone in ovariectomized cows. Neuroendocrinology 2008;88:212-215.
55.
Shahab M, Mastronardi C, Seminara SB, Crowley WF, Ojeda SR, Plant TM: Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primates. Proc Natl Acad Sci USA 2005;102:2129-2134.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.